Richard M Ransohoff. Show Affiliations »
Abstract
Mesh: See more » AnimalsApoptosisEncephalomyelitis, Autoimmune, Experimental/immunologyEncephalomyelitis, Autoimmune, Experimental/metabolismEncephalomyelitis, Autoimmune, Experimental/pathologyEncephalomyelitis, Autoimmune, Experimental/prevention & controlHumansInflammation/immunologyInflammation/metabolismInflammation/pathologyInflammation/prevention & controlMAP Kinase Signaling SystemMiceMultiple Sclerosis/immunologyMultiple Sclerosis/metabolismMultiple Sclerosis/prevention & controlMyelin Sheath/immunologyMyelin Sheath/pathologyNF-kappa B/metabolismNeuroglia/pathologyNeuroprotective Agents/immunologyNeuroprotective Agents/metabolismNeuroprotective Agents/therapeutic useT-Lymphocytes, Helper-Inducer/immunologyT-Lymphocytes, Helper-Inducer/metabolismalpha-Crystallin B Chain/geneticsalpha-Crystallin B Chain/immunologyalpha-Crystallin B Chain/metabolismalpha-Crystallin B Chain/therapeutic use
Substances: See more » NF-kappa BNeuroprotective Agentsalpha-Crystallin B Chain
Year: 2007 PMID: 17653181 DOI: 10.1038/448421a
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962